Viemed Q2 FY26 net income falls 12.45% to USD 2.76 million; revenue rises 23.9% to USD 78.1 million

Reuters2026/08/03 21:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Viemed Healthcare Q2 2026 revenue rose 23.9% year over year to USD 78.1 million, setting a quarterly record.
Net income attributable to shareholders fell to USD 2.8 million, or USD 0.07 per diluted share.
Adjusted EBITDA (non-GAAP) slipped 4% to USD 13.7 million, as Q2 2025 included a USD 1 million non-recurring disposal gain.
Ventilator patients climbed 4% from a year earlier to 12,635; PAP therapy patients more than doubled, rising 44% to 37,825.
Raised 2026 revenue outlook to USD 314 million-USD 320 million; adjusted EBITDA (non-GAAP) forecast narrowed to USD 64 million-USD 68 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viemed Healthcare Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608031700ACCESSWRNAPR_____1200721) on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Viemed Q2 FY26 net income falls 12.45% to USD 2.76 million; revenue rises 23.9% to USD 78.1 million

You may also like

Crypto prices